Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
20 Nov 2023
Reduced Blood Clot Risk with Post-hormonal Contraceptives
A recent study, revealing that the heightened risk of blood clots associated with hormonal contraceptives significantly diminishes after discontinuation, provides precise guidance on optimal contraceptive cessation timing.
18 Oct 2023
Positive Impact of Prenatal Iron Supplements
Iron supplementation during pregnancy has been shown to successfully reduce maternal anaemia. However, access is not universal. Read more about he direct dispensation of iron supplements during follow-ups
17 Oct 2023
Graft-Versus-Host Disease: Safety of Prophylactic Donor Lymphocyte Infusion
A research team conducted a retrospective study evaluating the efficacy and safety of prophylactic DLI for GVHD prophylaxis after PTCy-based haplo-HCT in paediatric patients with high-risk myeloid neoplasms.
27 Sep 2023
Update on Challenges in Diagnosis and Treatment of Myeloid Neoplasms with Systemic Mastocytosis
Concurrent systemic mastocytosis (SM) may often be missed in patients with myeloid neoplasms, such as, chronic myelomonocytic…
19 Sep 2023
Social Determinants of Health Could Worsen Survival in Cancers
Factors like health insurance, healthcare facility, education, income, and marital status were identified as key contributors in different outcomes for patients with haematologic malignancy in the USA. Read more…
18 Sep 2023
Allogeneic Haematopoietic Stem Cell Transplants and Acute Myeloid Leukaemia
Recent research suggests that administering intensive consolidation chemotherapy before allogeneic hematopoietic stem cell transplant doesn’t significantly improve outcomes compared to non-intensive consolidation in older adults with acute myeloid leukaemia.
11
Mins
14 Sep 2023
Improving the Effectiveness of Anticoagulant Therapy: The Promise of Factor XI Inhibition
This continuing medical education-accredited symposium, held at the 2023 International Society for Thrombosis and Haemostasis (ISTH)…
1 Sep 2023
Summer Highlights
Join the EMJ Editor, Evgenia Koutsouki, to rediscover some of this best summer highlights of The EMJ Podcast.
Loading posts...
« Previous
1
…
50
51
52
53
54
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View